Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLEX 404 Combined With Pemetrexed + Cisplatin in Advanced EGFR Wild-type NSCLC
NCT05764928Phase 2Not yet recruiting
- Sponsor
- Rgene
- Start
- Dec 2026
- Primary completion
- Dec 2027
- Modality
- Botanical drug
- Countries
- 1
01
Overview
A Phase 2 trial of bli-1401 in non-small cell lung cancer (NSCLC), sponsored by Rgene. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
bli-1401
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05764928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764928.